Analytical Validation Q2
Q2(R1)Validation
of Analytical Procedures: Text and MethodologyQ2A, Q2B
Finalised Guidelines:
October 1994/November 1996
Description:
The tripartite harmonised ICH Guideline on Text (previously coded Q2
Impurities Q3A - Q3D
- Q3A(R2)Impurities in New Drug
Substances
- Q3B(R2)Impurities in New Drug
Products
- Q3C(R5)Impurities: Guideline
for Residual SolventsQ3C, Q3C(M)
- Q3DImpurities: Guideline for
Metal Impurities
Pharmacopoeias Q4 - Q4B
- Q4Pharmacopoeias
- Q4APharmacopoeial
Harmonisation
- Q4BEvaluation and
Recommendation of Pharmacopoeial Texts for Use in the ICH Regions
- Q4B Annex 1R1Residue on
Ignition/Sulphated Ash General Chapter
- Q4B Annex 2R1Test for
Extractable Volume of Parenteral Preparations General Chapter
- Q4B Annex 3R1Test for Particulate
Contamination: Sub-Visible Particles General Chapter
- Q4B Annex 4AR1Microbiological
Examination of Non-Sterile Products: Microbial Enumeration Tests General
Chapter
- Q4B Annex 4BR1Microbiological
Examination of Non-Sterile Products: Tests for Specified Micro-Organisms
General Chapter
- Q4B Annex 4CR1Microbiological
Examination of Non-Sterile Products: Acceptance Criteria for
Pharmaceutical Preparations and Substances for Pharmaceutical Use General
Chapter
- Q4B Annex 5R1Disintegration
Test General Chapter
- Q4B Annex 6R1Uniformity of
Dosage Units General Chapter
- Q4B Annex 7R2Dissolution Test
General Chapter
- Q4B Annex 8R1Sterility Test
General Chapter
- Q4B Annex 9R1Tablet Friability
General Chapter
- Q4B Annex 10R1Polyacrylamide
Gel Electrophoresis General Chapter
- Q4B Annex 11Capillary
Electrophoresis General Chapter
- Q4B Annex 12Analytical Sieving
General Chapter
- Q4B Annex 13Bulk Density and
Tapped Density of Powders General Chapter
- Q4B Annex 14Bacterial
Endotoxins Test General Chapter
- Q4B FAQsFrequently Asked Questions
Quality of Biotechnological Products Q5A - Q5E
- Q5A(R1)Viral Safety Evaluation
of Biotechnology Products Derived from Cell Lines of Human or Animal
OriginQ5A
- Q5BAnalysis of the Expression
Construct in Cells Used for Production of r-DNA Derived Protein Products
- Q5CStability Testing of
Biotechnological/Biological Products
- Q5DDerivation and
Characterisation of Cell Substrates Used for Production of
Biotechnological/Biological Products
- Q5EComparability of
Biotechnological/Biological Products Subject to Changes in their
Manufacturing Process
Specifications
Q6A- Q6B
- Q6ASpecifications : Test
Procedures and Acceptance Criteria for New Drug Substances and New Drug
Products: Chemical Substances
- Q6BSpecifications : Test
Procedures and Acceptance Criteria for Biotechnological/Biological
Products
Good Manufacturing Practice Q7
- Q7Good Manufacturing Practice
Guide for Active Pharmaceutical IngredientsQ7A
- Q7 Q&AsQuestions and
Answers: Good Manufacturing Practice Guide for Active Pharmaceutical
Ingredients
Pharmaceutical Development Q8
- Q8(R2)Pharmaceutical
Development
- Q8/9/10 Q&AsR4Q8/Q9/Q10 -
Implementation
Quality Risk Management Q9
- Q9Quality Risk Management
- Q8/9/10 Q&AsR4Q8/Q9/Q10 -
Implementation
Pharmaceutical Quality System Q10
- Q10Pharmaceutical Quality
System
- Q8/9/10 Q&AsR4Q8/Q9/Q10 -
Implementation
Development and Manufacture of Drug Substances Q11
Q11Development
and Manufacture of Drug Substances (Chemical Entities and
Biotechnological/Biological Entities)
Finalised Guideline:
May 2012
0 comments:
Post a Comment